Toshio Shimokawa

Wakayama Medical University

Papers

1

Total Citations

20

H-Index

1

About

Toshio Shimokawa is a leading figure in clinical neurology and neurorehabilitation, with a particular focus on amyotrophic lateral sclerosis (ALS) and the integration of brain–machine interfaces (BMIs) into patient care. His landmark nationwide survey of 780 Japanese ALS patients, published in 2020, remains a cornerstone study, cited over 20 times for its comprehensive analysis of patient status and expectations from emerging BMI technologies. This work not only highlighted the profound physical and communicative challenges faced by ALS patients but also provided critical insights into their hopes for assistive devices, shaping future research directions in neuroprosthetics. Shimokawa’s contributions extend to advancing patient-centered approaches in neurology, bridging the gap between cutting-edge technology and real-world clinical needs. His research has been instrumental in informing healthcare policies and device development, ensuring that technological progress aligns with patient priorities. With a career dedicated to improving quality of life for individuals with neurodegenerative diseases, Shimokawa continues to influence both clinical practice and the ethical deployment of neurotechnology.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Nationwide survey of 780 Japanese patients with amyotrophic lateral sclerosis: their status and expectations from brain–machine interfaces
20 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Wakayama Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago